Recently, the world's first interventional brain-computer interface (BCI)-assisted human limb motor function restoration trial has been completed in China, successfully helping a hemiplegic patient to regain partial motor function.

This achievement demonstrates China's independent innovation capability in core BCI technology, marking a critical step forward for interventional BCI technology in China within the fields of precise control, neural reconstruction, and intelligent rehabilitation. It provides a novel therapeutic approach and renewed hope for patients suffering from motor impairments due to stroke, paraplegia, amyotrophic lateral sclerosis, and other neurological conditions.

This research was led by the team of Professor Duan Feng from NKU, in collaboration with Professor Lin Zhixiong from Sanbo Brain Hospital and Professor Wu Chenghan from Fujian Provincial Second People's Hospital. Leveraging the interventional BCI system independently developed by the NKU team and building upon the solid foundation in neurosurgery of Professor Lin Zhixiong's team at Fujian Sanbo Funeng Brain Hospital as well as their clinical experience in the BCI field, the trial was successfully completed with support from Tianjin Jianjia Rehabilitation Hospital, the PLA Air Force Characteristic Medical Center, and Tianjin Rongyuan Intelligent Technology Co., Ltd.

The trial represents the first interventional BCI human clinical trial by Professor Duan Feng's team, following their groundbreaking achievements in the world's first interventional BCI non-human primate experiment and the world's first interventional BCI sensor intravascular retrieval trial. It serves as a significant milestone in the clinical application of interventional BCI technology.